Brief: Lsl Pharma Group Expands Its Activities By Aquiring Dermolab Pharma
18/12/2024 13:35
Dec 18 (Reuters) - LSL Pharma Group Inc LSL.V :
* LSL PHARMA GROUP EXPANDS ITS ACTIVITIES BY AQUIRING
DERMOLAB
PHARMA AND ANNOUNCES THE CLOSING OF A CONCURRENT DEBT FINANCING
Source text: ID:nCNW3jfL2a
Further company coverage: LSL.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LSL Pharma
See all newsBrief: LSL Pharma Group Announces CFO Transition
Canada's LSL Pharma Q2 revenue surges on acquisition boost, eye-drop launches
Brief: Lsl Pharma Group Reports Record Revenues And Second Quarter 2026 Results
Brief: LSL Pharma Group Successfully Obtained U.S. FDA Certification For The Manufacturing Of Ophthalmic Ointments For Commercialization In The United States
Brief: LSL Pharma Group Announces Closing Of The Acquisition Of Juno Otc And Final $2M Closing Of Upsized $12M Offering